Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
M Pai, LW Riley, JM Colford - The Lancet infectious diseases, 2004 - thelancet.com
A major challenge in tuberculosis control is the diagnosis and treatment of latent tuberculosis
infection. Until recently, there were no alternatives to the tuberculin skin test (TST) for …
infection. Until recently, there were no alternatives to the tuberculin skin test (TST) for …
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
BACKGROUND: Despite certain drawbacks, the tuberculin skin test (TST) remains in
widespread use. Important advantages of the TST are its low cost, simplicity and interpretation …
widespread use. Important advantages of the TST are its low cost, simplicity and interpretation …
Systematic review: T-cell–based assays for the diagnosis of latent tuberculosis infection: an update
M Pai, A Zwerling, D Menzies - Annals of internal medicine, 2008 - acpjournals.org
… Pai serves as an external consultant for the Foundation for Innovative New Diagnostics,
Geneva, a nonprofit agency that collaborates with several industry partners, including Cellestis, …
Geneva, a nonprofit agency that collaborates with several industry partners, including Cellestis, …
[BOOK][B] Power system dynamics and stability: with synchrophasor measurement and power system toolbox
… power system toolbox/ Peter W Sauer, M. A Pai, University of Illinois at Urbana-Champaign, …
The line has voltages and currents at its sending end (k) and receiving end (m). The voltage …
The line has voltages and currents at its sending end (k) and receiving end (m). The voltage …
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American …
…, JS Bradley, C Liu, BA Mueller, MP Pai… - American Journal of …, 2020 - academic.oup.com
Methods These are the consensus statements and guideline of ASHP, IDSA, the Pediatric
Infectious Diseases Society (PIDS), and SIDP. Guideline panel composition consisted of …
Infectious Diseases Society (PIDS), and SIDP. Guideline panel composition consisted of …
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of …
…, M Pai, L Richeldi, M Salfinger… - Clinical Infectious …, 2017 - academic.oup.com
Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms
and signs of disease (tuberculosis disease) or may have no clinical evidence of disease …
and signs of disease (tuberculosis disease) or may have no clinical evidence of disease …
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
… When culture data were available for both M tuberculosis and nontuberculous mycobacteria,
we calculated sensitivity and specificity based on cultures positive for M tuberculosis alone. …
we calculated sensitivity and specificity based on cultures positive for M tuberculosis alone. …
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study
Background . Inadequate antimicrobial treatment is an independent determinant of hospital
mortality, and fungal bloodstream infections are among the types of infection with the highest …
mortality, and fungal bloodstream infections are among the types of infection with the highest …
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Background Accurate, rapid detection of tuberculosis (TB) and TB drug resistance is critical
for improving patient care and decreasing TB transmission. Xpert® MTB/RIF assay is an …
for improving patient care and decreasing TB transmission. Xpert® MTB/RIF assay is an …
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection
M Pai, CM Denkinger, SV Kik… - Clinical microbiology …, 2014 - Am Soc Microbiol
Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI. …
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI. …